Skip to content
OpenCapital
Get started

Odyssey Therapeutics, Inc. ODTX Business Segments

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
Q1 '26
Business Combination Contingent Consideration Liability Measurement Input by Product
MDA53,500%—
NLRP13,500%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Odyssey Therapeutics, Inc. break its business down?
Odyssey Therapeutics, Inc. (ODTX) reports business combination contingent consideration liability measurement input by product across 2 parts — MDA5 and NLRP1. Each is extracted from the segment footnotes and tracked over time.
Where does Odyssey Therapeutics, Inc.'s segment data come from?
Segment breakdowns are pulled from the segment footnotes in Odyssey Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.